Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system

The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous efforts have been made to model it in order to analyze normal or pathological hematopoiesis and its stromal counterpart. Herein, we report an original...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 15; no. 1; pp. 23603 - 13
Main Authors Schell, Bérénice, Zhao, Lin-Pierre, M’Sibih, Inés, Kalogeraki, Maria, Kergaravat, Camille, Lereclus, Emilie, Fenaux, Pierre, Adès, Lionel, Toubert, Antoine, Espéli, Marion, Balabanian, Karl, Clave, Emmanuel, Dulphy, Nicolas, Bisio, Valeria
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 02.07.2025
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text
ISSN2045-2322
2045-2322
DOI10.1038/s41598-025-07717-9

Cover

Abstract The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous efforts have been made to model it in order to analyze normal or pathological hematopoiesis and its stromal counterpart. Herein, we report an original, fully-human in vitro 3D model of the BM microenvironment dedicated to study interactions taking place between mesenchymal stromal cells (MSC) and hematopoietic stem and progenitor cells (HSPC) during the hematopoietic differentiation. This fully-human Artificial Marrow Organoid (AMO) model is highly efficient to recapitulate MSC support to myeloid differentiation and NK cell development from the immature CD34 + HSPCs to the most terminally differentiated CD15 + polymorphonuclear neutrophils, CD64 + monocytes or NKG2A-KIR2D + CD57 + NK subset. Lastly, our model is suitable for evaluating anti-leukemic NK cell function in presence of therapeutic agents. Overall, the AMO is a versatile, low cost and simple model able to recapitulate normal hematopoiesis and allowing more physiological drug testing by taking into account both immune and non-immune BM microenvironment interactions.
AbstractList The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous efforts have been made to model it in order to analyze normal or pathological hematopoiesis and its stromal counterpart. Herein, we report an original, fully-human in vitro 3D model of the BM microenvironment dedicated to study interactions taking place between mesenchymal stromal cells (MSC) and hematopoietic stem and progenitor cells (HSPC) during the hematopoietic differentiation. This fully-human Artificial Marrow Organoid (AMO) model is highly efficient to recapitulate MSC support to myeloid differentiation and NK cell development from the immature CD34 + HSPCs to the most terminally differentiated CD15 + polymorphonuclear neutrophils, CD64 + monocytes or NKG2A-KIR2D + CD57 + NK subset. Lastly, our model is suitable for evaluating anti-leukemic NK cell function in presence of therapeutic agents. Overall, the AMO is a versatile, low cost and simple model able to recapitulate normal hematopoiesis and allowing more physiological drug testing by taking into account both immune and non-immune BM microenvironment interactions.
The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous efforts have been made to model it in order to analyze normal or pathological hematopoiesis and its stromal counterpart. Herein, we report an original, fully-human in vitro 3D model of the BM microenvironment dedicated to study interactions taking place between mesenchymal stromal cells (MSC) and hematopoietic stem and progenitor cells (HSPC) during the hematopoietic differentiation. This fully-human Artificial Marrow Organoid (AMO) model is highly efficient to recapitulate MSC support to myeloid differentiation and NK cell development from the immature CD34 + HSPCs to the most terminally differentiated CD15 + polymorphonuclear neutrophils, CD64 + monocytes or NKG2A-KIR2D + CD57 + NK subset. Lastly, our model is suitable for evaluating anti-leukemic NK cell function in presence of therapeutic agents. Overall, the AMO is a versatile, low cost and simple model able to recapitulate normal hematopoiesis and allowing more physiological drug testing by taking into account both immune and non-immune BM microenvironment interactions.
The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous efforts have been made to model it in order to analyze normal or pathological hematopoiesis and its stromal counterpart. Herein, we report an original, fully-human in vitro 3D model of the BM microenvironment dedicated to study interactions taking place between mesenchymal stromal cells (MSC) and hematopoietic stem and progenitor cells (HSPC) during the hematopoietic differentiation. This fully-human Artificial Marrow Organoid (AMO) model is highly efficient to recapitulate MSC support to myeloid differentiation and NK cell development from the immature CD34 + HSPCs to the most terminally differentiated CD15 + polymorphonuclear neutrophils, CD64 + monocytes or NKG2A-KIR2D + CD57 + NK subset. Lastly, our model is suitable for evaluating anti-leukemic NK cell function in presence of therapeutic agents. Overall, the AMO is a versatile, low cost and simple model able to recapitulate normal hematopoiesis and allowing more physiological drug testing by taking into account both immune and non-immune BM microenvironment interactions.The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous efforts have been made to model it in order to analyze normal or pathological hematopoiesis and its stromal counterpart. Herein, we report an original, fully-human in vitro 3D model of the BM microenvironment dedicated to study interactions taking place between mesenchymal stromal cells (MSC) and hematopoietic stem and progenitor cells (HSPC) during the hematopoietic differentiation. This fully-human Artificial Marrow Organoid (AMO) model is highly efficient to recapitulate MSC support to myeloid differentiation and NK cell development from the immature CD34 + HSPCs to the most terminally differentiated CD15 + polymorphonuclear neutrophils, CD64 + monocytes or NKG2A-KIR2D + CD57 + NK subset. Lastly, our model is suitable for evaluating anti-leukemic NK cell function in presence of therapeutic agents. Overall, the AMO is a versatile, low cost and simple model able to recapitulate normal hematopoiesis and allowing more physiological drug testing by taking into account both immune and non-immune BM microenvironment interactions.
Abstract The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous efforts have been made to model it in order to analyze normal or pathological hematopoiesis and its stromal counterpart. Herein, we report an original, fully-human in vitro 3D model of the BM microenvironment dedicated to study interactions taking place between mesenchymal stromal cells (MSC) and hematopoietic stem and progenitor cells (HSPC) during the hematopoietic differentiation. This fully-human Artificial Marrow Organoid (AMO) model is highly efficient to recapitulate MSC support to myeloid differentiation and NK cell development from the immature CD34 + HSPCs to the most terminally differentiated CD15 + polymorphonuclear neutrophils, CD64 + monocytes or NKG2A-KIR2D + CD57 + NK subset. Lastly, our model is suitable for evaluating anti-leukemic NK cell function in presence of therapeutic agents. Overall, the AMO is a versatile, low cost and simple model able to recapitulate normal hematopoiesis and allowing more physiological drug testing by taking into account both immune and non-immune BM microenvironment interactions.
ArticleNumber 23603
Author Adès, Lionel
Toubert, Antoine
Kergaravat, Camille
M’Sibih, Inés
Balabanian, Karl
Bisio, Valeria
Fenaux, Pierre
Schell, Bérénice
Zhao, Lin-Pierre
Kalogeraki, Maria
Lereclus, Emilie
Clave, Emmanuel
Dulphy, Nicolas
Espéli, Marion
Author_xml – sequence: 1
  givenname: Bérénice
  surname: Schell
  fullname: Schell, Bérénice
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis
– sequence: 2
  givenname: Lin-Pierre
  surname: Zhao
  fullname: Zhao, Lin-Pierre
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis, Department d’Hématologie Senior, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris
– sequence: 3
  givenname: Inés
  surname: M’Sibih
  fullname: M’Sibih, Inés
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis
– sequence: 4
  givenname: Maria
  surname: Kalogeraki
  fullname: Kalogeraki, Maria
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis
– sequence: 5
  givenname: Camille
  surname: Kergaravat
  fullname: Kergaravat, Camille
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis
– sequence: 6
  givenname: Emilie
  surname: Lereclus
  fullname: Lereclus, Emilie
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis, Direction de la Recherche Clinique et Innovation, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis
– sequence: 7
  givenname: Pierre
  surname: Fenaux
  fullname: Fenaux, Pierre
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis, Department d’Hématologie Senior, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris
– sequence: 8
  givenname: Lionel
  surname: Adès
  fullname: Adès, Lionel
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis, Department d’Hématologie Senior, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris
– sequence: 9
  givenname: Antoine
  surname: Toubert
  fullname: Toubert, Antoine
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis, Laboratoire d’Immunologie et d‘Histocompatibilité, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis
– sequence: 10
  givenname: Marion
  surname: Espéli
  fullname: Espéli, Marion
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis
– sequence: 11
  givenname: Karl
  surname: Balabanian
  fullname: Balabanian, Karl
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis
– sequence: 12
  givenname: Emmanuel
  surname: Clave
  fullname: Clave, Emmanuel
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis
– sequence: 13
  givenname: Nicolas
  surname: Dulphy
  fullname: Dulphy, Nicolas
  email: nicolas.dulphy@u-paris.fr
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis, Laboratoire d’Immunologie et d‘Histocompatibilité, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Louis
– sequence: 14
  givenname: Valeria
  surname: Bisio
  fullname: Bisio, Valeria
  email: valeria.bisio@inserm.fr
  organization: Université Paris Cité, Institut de Recherche Saint Louis, INSERM UMR1342, Leukemia Institute Paris Saint-Louis
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40604201$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v1DAQtVARLaV_gAOyxIVLwPFHbJ8QKl-VirjA2XKcya5Xib3YSav99zibUloOzGU89nvPTzPzHJ2EGAChlzV5WxOm3mVeC60qQkVFpKxlpZ-gM0q4qCij9OTB-RRd5LwjJQTVvNbP0CknDeGU1GcofIsdDD5s8AgZgtseRjvgPKW4ZAdDKeb9PqYJTxFvYbRT3EcP2Wd866etD9jiEG9gwOwjtmnyvXe-UEebUrzFMW1siL7D-ZAnGF-gp70dMlzc5XP08_OnH5dfq-vvX64uP1xXjms-VVYx12nZybaVIGzHuBQtZUJaohgDrnurpQNNlLTUOup6phTrGVVCLDU7R1erbhftzuyTL3YOJlpvjhfFlVm8ugEME7plimkhlOM95UXUlgYr7qjoGwtF6_2qtZ_bEToHYUp2eCT6-CX4rdnEG1PTEpyrovDmTiHFXzPkyYw-L721AeKcTRlSI-tGalmgr_-B7uKcQunVESU0IQ0vqFcPLd17-TPXAqArwKWYc4L-HlITs-yPWffHlP0xx_0xupDYSsoFHDaQ_v79H9Zv7NrIMg
Cites_doi 10.1146/annurev-immunol-101921-044122
10.1080/2162402X.2015.1017701
10.1186/s12915-022-01264-9
10.1016/j.celrep.2016.05.095
10.1111/j.1365-2141.1994.tb05104.x
10.18632/oncotarget.6213
10.3389/fimmu.2020.571085
10.1016/j.exphem.2020.11.008
10.1016/j.biomaterials.2009.11.094
10.1016/j.nbd.2023.106156
10.3324/haematol.2011.050815
10.1002/jbm4.10516
10.1158/2643-3230.BCD-23-0202
10.1182/blood-2014-10-570234
10.1016/j.jphotobiol.2017.03.024
10.1016/bs.mie.2019.05.036
10.3389/fimmu.2014.00423
10.3389/fimmu.2017.00458
10.3389/fimmu.2019.01812
10.1038/nri2024
10.1038/35030112
10.1038/s41467-023-36193-w
10.1007/978-1-0716-1425-9_1
10.3389/fimmu.2023.1195194
10.1038/s41586-023-06945-1
10.1007/s00262-017-2014-y
10.1089/scd.2014.0597
10.1016/j.immuni.2005.01.013
10.1182/blood-2014-12-570200
10.3389/fimmu.2016.00413
10.3389/fimmu.2021.631279
10.4049/jimmunol.2200836
10.1186/s13287-023-03381-w
10.1182/blood-2023-191081
10.1146/annurev-immunol-020711-074942
10.3389/fonc.2021.733652
10.1111/cas.16066
10.1182/blood-2014-09-570192
10.1182/asheducation-2017.1.73
10.1084/jem.20231222
10.1038/nmeth.4237
ContentType Journal Article
Copyright The Author(s) 2025
2025. The Author(s).
The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: 2025. The Author(s).
– notice: The Author(s) 2025. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s41598-025-07717-9
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
ProQuest Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
Publicly Available Content Database
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 13
ExternalDocumentID oai_doaj_org_article_359b3839558c4f24908a03884c25f6ae
PMC12222448
40604201
10_1038_s41598_025_07717_9
Genre Journal Article
GrantInformation_xml – fundername: Association Laurette Fugain
  grantid: ALF 2016-07
  funderid: http://dx.doi.org/10.13039/100007394
– fundername: Fondation de France
  funderid: http://dx.doi.org/10.13039/501100004431
– fundername: IHU THEMA
– fundername: Ligue contre le Cancer
– fundername: Cancéropôle Ile-de-France
– fundername: French Ministry of Health and the French National Cancer Institute
  grantid: PRT-K2017-109; PRT-K2017-109; PRT-K2017-109
– fundername: ITMO Cancer of Aviesan
– fundername: Association Force Hémato
– fundername: French Ministry of Health and the French National Cancer Institute
  grantid: PRT-K2017-109
– fundername: Association Laurette Fugain
  grantid: ALF 2016-07
GroupedDBID 0R~
4.4
53G
5VS
7X7
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
AASML
ABDBF
ABUWG
ACGFS
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AFPKN
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M1P
M2P
M7P
M~E
NAO
OK1
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
88A
8FK
AARCD
K9.
M48
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c494t-a83cd97d7bb7e5ad3475b2357a0833e49fa97ce9087a2ac2cf3883f328552ac23
IEDL.DBID C6C
ISSN 2045-2322
IngestDate Wed Aug 27 01:30:22 EDT 2025
Thu Aug 21 18:32:52 EDT 2025
Fri Sep 05 15:44:36 EDT 2025
Wed Aug 13 08:37:21 EDT 2025
Mon Jul 21 06:00:02 EDT 2025
Thu Jul 10 07:58:31 EDT 2025
Mon Jul 21 06:06:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c494t-a83cd97d7bb7e5ad3475b2357a0833e49fa97ce9087a2ac2cf3883f328552ac23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.nature.com/articles/s41598-025-07717-9
PMID 40604201
PQID 3226590064
PQPubID 2041939
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_359b3839558c4f24908a03884c25f6ae
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12222448
proquest_miscellaneous_3226716797
proquest_journals_3226590064
pubmed_primary_40604201
crossref_primary_10_1038_s41598_025_07717_9
springer_journals_10_1038_s41598_025_07717_9
PublicationCentury 2000
PublicationDate 2025-07-02
PublicationDateYYYYMMDD 2025-07-02
PublicationDate_xml – month: 07
  year: 2025
  text: 2025-07-02
  day: 02
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2025
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References 7717_CR3
O Kyrysyuk (7717_CR12) 2023; 41
M Boy (7717_CR24) 2023; 14
PE Boulais (7717_CR25) 2015; 125
7717_CR4
MWH Roeven (7717_CR16) 2015; 24
D Jing (7717_CR30) 2012; 97
J Cany (7717_CR17) 2015; 4
S Sangaletti (7717_CR31) 2017; 66
SS Chung (7717_CR34) 2017; 2017
C Restelli (7717_CR27) 2024; 5
C Qi (7717_CR35) 2023; 183
YS Rocca (7717_CR41) 2016; 7
V Bisio (7717_CR39) 2021; 2308
C Dussiau (7717_CR33) 2022; 20
AG Freud (7717_CR37) 2016; 16
7717_CR8
TM Blanco (7717_CR19) 2010; 31
7717_CR21
7717_CR40
J Ropa (7717_CR29) 2023; 142
CS Seet (7717_CR18) 2017; 14
M Syrjälä (7717_CR20) 1994; 88
E Vivier (7717_CR13) 2024; 626
P Sommerkamp (7717_CR2) 2021; 94
CA Soto (7717_CR26) 2021; 5
A de Janon (7717_CR5) 2023; 210
M Peshkova (7717_CR28) 2023; 14
F Rosenbauer (7717_CR9) 2007; 7
M Sakurai (7717_CR36) 2024; 115
LT Vo (7717_CR7) 2015; 125
Y Lang (7717_CR1) 2023; 14
CJ Eaves (7717_CR6) 2015; 125
7717_CR15
S Shah (7717_CR22) 2017; 170
LL Lanier (7717_CR14) 2024; 221
AG Freud (7717_CR38) 2005; 22
B Amulic (7717_CR32) 2012; 30
E Sohlberg (7717_CR23) 2015; 6
M Kondo (7717_CR11) 2000; 407
7717_CR10
References_xml – volume: 41
  start-page: 17
  year: 2023
  ident: 7717_CR12
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-101921-044122
– volume: 4
  start-page: e1017701
  year: 2015
  ident: 7717_CR17
  publication-title: OncoImmunology
  doi: 10.1080/2162402X.2015.1017701
– volume: 20
  start-page: 60
  year: 2022
  ident: 7717_CR33
  publication-title: BMC Biol.
  doi: 10.1186/s12915-022-01264-9
– volume: 16
  start-page: 379
  year: 2016
  ident: 7717_CR37
  publication-title: Cell. Rep.
  doi: 10.1016/j.celrep.2016.05.095
– volume: 88
  start-page: 679
  year: 1994
  ident: 7717_CR20
  publication-title: Br. J. Haematol.
  doi: 10.1111/j.1365-2141.1994.tb05104.x
– volume: 6
  start-page: 34178
  year: 2015
  ident: 7717_CR23
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6213
– ident: 7717_CR10
  doi: 10.3389/fimmu.2020.571085
– volume: 94
  start-page: 20
  year: 2021
  ident: 7717_CR2
  publication-title: Exp. Hematol.
  doi: 10.1016/j.exphem.2020.11.008
– volume: 31
  start-page: 2243
  year: 2010
  ident: 7717_CR19
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.11.094
– volume: 183
  start-page: 106156
  year: 2023
  ident: 7717_CR35
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2023.106156
– volume: 97
  start-page: 331
  year: 2012
  ident: 7717_CR30
  publication-title: Haematologica
  doi: 10.3324/haematol.2011.050815
– volume: 5
  start-page: e10516
  year: 2021
  ident: 7717_CR26
  publication-title: JBMR Plus
  doi: 10.1002/jbm4.10516
– volume: 5
  start-page: 234
  year: 2024
  ident: 7717_CR27
  publication-title: Blood Cancer Discov
  doi: 10.1158/2643-3230.BCD-23-0202
– volume: 125
  start-page: 2641
  year: 2015
  ident: 7717_CR7
  publication-title: Blood
  doi: 10.1182/blood-2014-10-570234
– volume: 170
  start-page: 65
  year: 2017
  ident: 7717_CR22
  publication-title: J. Photochem. Photobiol B
  doi: 10.1016/j.jphotobiol.2017.03.024
– ident: 7717_CR40
  doi: 10.1016/bs.mie.2019.05.036
– ident: 7717_CR8
  doi: 10.3389/fimmu.2014.00423
– ident: 7717_CR15
  doi: 10.3389/fimmu.2017.00458
– ident: 7717_CR21
  doi: 10.3389/fimmu.2019.01812
– volume: 7
  start-page: 105
  year: 2007
  ident: 7717_CR9
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2024
– volume: 407
  start-page: 383
  year: 2000
  ident: 7717_CR11
  publication-title: Nature
  doi: 10.1038/35030112
– volume: 14
  start-page: 588
  year: 2023
  ident: 7717_CR24
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-36193-w
– volume: 2308
  start-page: 3
  year: 2021
  ident: 7717_CR39
  publication-title: Methods Mol. Biol. Clifton NJ
  doi: 10.1007/978-1-0716-1425-9_1
– volume: 14
  start-page: 1195194
  year: 2023
  ident: 7717_CR1
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2023.1195194
– volume: 626
  start-page: 727
  year: 2024
  ident: 7717_CR13
  publication-title: Nature
  doi: 10.1038/s41586-023-06945-1
– volume: 66
  start-page: 1059
  year: 2017
  ident: 7717_CR31
  publication-title: Cancer Immunol. Immunother CII
  doi: 10.1007/s00262-017-2014-y
– volume: 24
  start-page: 2886
  year: 2015
  ident: 7717_CR16
  publication-title: Stem Cells Dev.
  doi: 10.1089/scd.2014.0597
– volume: 22
  start-page: 295
  year: 2005
  ident: 7717_CR38
  publication-title: Immunity
  doi: 10.1016/j.immuni.2005.01.013
– volume: 125
  start-page: 2605
  year: 2015
  ident: 7717_CR6
  publication-title: Blood
  doi: 10.1182/blood-2014-12-570200
– volume: 7
  start-page: 413
  year: 2016
  ident: 7717_CR41
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2016.00413
– ident: 7717_CR3
  doi: 10.3389/fimmu.2021.631279
– volume: 210
  start-page: 895
  year: 2023
  ident: 7717_CR5
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.2200836
– volume: 14
  start-page: 142
  year: 2023
  ident: 7717_CR28
  publication-title: Stem Cell. Res. Ther.
  doi: 10.1186/s13287-023-03381-w
– volume: 142
  start-page: 1307
  year: 2023
  ident: 7717_CR29
  publication-title: Blood
  doi: 10.1182/blood-2023-191081
– volume: 30
  start-page: 459
  year: 2012
  ident: 7717_CR32
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-020711-074942
– ident: 7717_CR4
  doi: 10.3389/fonc.2021.733652
– volume: 115
  start-page: 698
  year: 2024
  ident: 7717_CR36
  publication-title: Cancer Sci.
  doi: 10.1111/cas.16066
– volume: 125
  start-page: 2621
  year: 2015
  ident: 7717_CR25
  publication-title: Blood
  doi: 10.1182/blood-2014-09-570192
– volume: 2017
  start-page: 73
  year: 2017
  ident: 7717_CR34
  publication-title: Hematol. Am. Soc. Hematol. Educ. Program.
  doi: 10.1182/asheducation-2017.1.73
– volume: 221
  start-page: e20231222
  year: 2024
  ident: 7717_CR14
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20231222
– volume: 14
  start-page: 521
  year: 2017
  ident: 7717_CR18
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.4237
SSID ssj0000529419
Score 2.4556034
Snippet The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous efforts...
Abstract The human bone marrow (BM) microenvironment involves hematopoietic and non-hematopoietic cell subsets organized in a complex architecture. Tremendous...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 23603
SubjectTerms 631/250/232/2058
631/250/232/2059
631/532/1542
Bone marrow
Bone Marrow - metabolism
Bone Marrow Cells - cytology
CD34 antigen
CD57 antigen
Cell Differentiation
Cells
Cytokines
Experiments
Flow cytometry
Granulocytes
Hematopoiesis
Hematopoietic stem cells
Hematopoietic Stem Cells - cytology
Hematopoietic Stem Cells - metabolism
Hemopoiesis
Humanities and Social Sciences
Humans
Killer Cells, Natural - cytology
Killer Cells, Natural - metabolism
Leukemia
Leukocytes (neutrophilic)
Leukocytes (polymorphonuclear)
Localization
Mesenchymal stem cells
Mesenchymal Stem Cells - cytology
Mesenchymal Stem Cells - metabolism
Microenvironments
Microscopy
Models, Biological
Monocytes
multidisciplinary
Natural killer cells
NKG2 antigen
Organoids
Organoids - cytology
Organoids - metabolism
Potassium channels (inwardly-rectifying)
Progenitor cells
Reproducibility
Science
Science (multidisciplinary)
Stromal cells
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hSpW4IKA8UgoyEjeImsZ2HB-hUFVIcKJSb5bt2OpKbLJqskj998zY2aXLQ1x6ihL74MyM7W88nm8A3lSdi6rRvrSx6krRuYBTyqpSiS62QXDcAslR_PK1Ob8Qny_l5a1SX3QnLNMDZ8Edc6kdelFaytaLWFOcyhKDifC1jI0NtPpWurrlTGVW71qLEz1nyWD_4xF3Ksomq2VZKfRhSr2zEyXC_r-hzD8vS_4WMU0b0dlDeDAjSPY-j_wR3Av9Y9jPNSVvDqCn6maUY86WlFjkr26W2Hucrgd60jk9G9crQt1sGliibB1WA_rLi5HRoeyiZ5b1w4_wnfGPjOSTOSbYMtE1slQGalh0LHNAP4GLs0_fTs_LuahC6YUWU2lb7jutOuWcCtJ2XCjpiPPGIhjjQehotfIBxaxsbX3tIwqbR163UtI7fwp7_dCH58DQFVKNlCE6x0V0QgcnpXMVF5bLxnUFvN0I2Kwyd4ZJMW_emqwOg-owSR1GF_CBdLDtSbzX6QP-l5mtwfzPGgo42mjQzJNxNLhmNVQctREFvN424zQimds-DOvcR1FIShXwLCt8OxJBBEMIlApod0xhZ6i7Lf3iKlF1nyD8QgDVFvBuYzW_xvVvWRzehSxewP06mzta_RHsTdfr8BIR1ORepcnyE5SLFy8
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection (Proquest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BERIX1PJq2oKMxA2iZmM7tk8VUKoKCU5U2pvlp7oSmyxNFqn_Ho-T3Wp5naLEPjieGfubGfsbgDeVt1E0ypUmVr5k3oZkUkaUgvkoA6NpC0RH8cvX5vKKfZ7z-RRw66djlZs1MS_UvnMYIz9NitdghcuGna1-lFg1CrOrUwmN-_BglpAIlm4Qc7GNsWAWi83UdFemovK0T_sV3imreVmJ5MmUamc_yrT9f8Oafx6Z_C1vmreji314POFI8n4U_AHcC-0TeDhWlrx9Ci3WOMOb5mSJ14vc9e0y9e6Hmw6fGK0n_XqF2JsMHcnErd2qS17zoicYml20xJC2-xm-E3pOUL1GpgmyzKSNJBeD6haejEzQz-Dq4tO3j5flVFqhdEyxoTSSOq-EF9aKwI2nTHCLzDcmQTIamIpGCRdUJYWpjatdpFLSSGvJOb7T57DXdm04BJIcItFwHqK1lEXLVLCcW1tRZihvrC_g7WaC9Wpk0NA5802lHsWhkzh0FodWBXxAGWx7Ivt1_pD-S0_GpClXNnnWinPpWKwxd2mQ1Ya5msfGhAJONhLUk0n2-k6BCni9bU7GhHNu2tCtxz4CE1OigBejwLcjYUgzlOBSAXJHFXaGutvSLq4zYfcsgbAEo2QB7zZaczeuf8_F0f9_4xge1aMiJ30-gb3hZh1eJoQ02FfZDH4BIBYP4w
  priority: 102
  providerName: ProQuest
Title Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system
URI https://link.springer.com/article/10.1038/s41598-025-07717-9
https://www.ncbi.nlm.nih.gov/pubmed/40604201
https://www.proquest.com/docview/3226590064
https://www.proquest.com/docview/3226716797
https://pubmed.ncbi.nlm.nih.gov/PMC12222448
https://doaj.org/article/359b3839558c4f24908a03884c25f6ae
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_6wWAvY9_z2gUN9raZuZZkSY9p1lICK2NbIW9CsiUaaOxQO4P-99XJdka27mFPwtYZZN2ddKfT_Q7gQ1ZZLwpVpsZnVcoq64JKGZEKVnnpGA1bIDqKXy-Liys2X_DFHuRjLky8tB8hLeMyPd4O-9yGjQaTwXKeZiK4IKnah0MpKEepnhWz7bkKRq7YiRryYzIqH_h0Zw-KUP0P2Zd_X5P8I1Yat6Dzp_BksB3JtB_tM9hz9XN41FeTvHsBNdY1w-xyssKUovL6bhWo2-62wRZP6Em7WaO9TbqGRLDWZt0ET3nZEjyOXdbEkLr55W4I_UJwTnp0CbKKQI0kFoBqlhXp0Z9fwtX52c_ZRTqUU0hLpliXGknLSolKWCscNxVlgltEuzHBDKOOKW-UKJ3KpDC5KfPSUympp7nkHJ_pKziom9q9ARKcIFFw7ry1lHnLlLOcW5tRZgJHbJXAx3GC9bpHzdAx2k2l7tmhAzt0ZIdWCZwiD7aUiHgdX4T_0oMEaMqVDd604lyWzOcYrzSIZMPKnPvCuASORw7qQQ1bHVarAsuiFiyB99vuoEA456Z2zaanERiMEgm87hm-HQlDaKFgIiUgd0RhZ6i7PfXyOoJ0nwTDK5hOMoFPo9T8Hte_5-Lt_5EfweO8F-wg38dw0N1u3LtgJXV2AvtiISZwOJ3Of8xDe3p2-e37JCrLJJ483APMIBLb
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrRBcEG8CBYwEJ4iaxnYcHypEaastbVcItVJvrh076kpssjS7oP1z_DY8TrLV8rr1FCWxItszY894Mt8H8DqxphSZLGJdJjZm1jhvUlrEgtkyd4z6LRADxeNRNjxln8742Rr87Gth8LfKfk0MC7WtCzwj3_SKlyHDZcbeT7_FyBqF2dWeQkN31Ap2O0CMdYUdh27xw4dwzfbBrpf3mzTd3zv5OIw7loG4YJLNYp3TwkphhTHCcW0pE9wgCIz23gl1TJZaisLJJBc61UValDTPaUnTnHO8p_67N2Cd4QHKANZ39kafvyxPeTCPxrZkV62T0Hyz8TsmVrWlPE6Ej6ViubIjBuKAv3m7f_60-VvmNmyI-3fhTufJkg-t6t2DNVfdh5stt-XiAVTIsoa17mSCBU7FxWLiWzezyxqvmC8gzXyK3j-Z1SRAx9bT2sft44bg4fC4IppU9Xf3ldBdggreYl2QSYCNJIGOqh5b0mJRP4TTa5n2RzCo6so9AeJDMpFx7kpjKCsNk85wbkxCmaY8MzaCt_0Eq2mL4aFC7p3mqhWH8uJQQRxKRrCDMli2RPzt8MCPS3XmrCiXxsf2kvO8YGWK2VONuDqsSHmZaRfBRi9B1S0KjbpS4QheLV97c8Y515Wr520bgakxEcHjVuDLnjAEOvIOWwT5iiqsdHX1TTW-CJDhW94N9I5cHsG7Xmuu-vXvuXj6_2G8hFvDk-MjdXQwOnwGt9NWqb1ub8Bgdjl3z72_NjMvOqMgcH7ddvgLrnBTSw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIhAXxLMEChgJThBtGtuxfUAIWFYthYoDlXozdmKrK7HJ0uyC9q_x6_A4yVbL69ZTlMSKHM-MPePxfB_A06yyXhSqTI3PqpRV1gWTMiIVrPLSMRqWQAwUPx4V-8fs_Qk_2YKfQy0MHqsc5sQ4UVdNiXvko6B4BTJcFmzk-2MRn8aTV_NvKTJIYaZ1oNPoVOTQrX6E8K19eTAOsn6W55N3n9_upz3DQFoyxRapkbSslKiEtcJxU1EmuEUAGBM8E-qY8kaJ0qlMCpObMi89lZJ6mkvO8Z6G716Cy4IyhrQR4kSs93cwg8b2VF-nk1E5asNaifVsOU8zEaKoVG2shZEy4G9-7p_HNX_L2calcHIDrvc-LHndKd1N2HL1LbjSsVqubkON_GpY5U5mWNpUnq5moXW7OGvwipkC0i7n6PeTRUMiaGwzb0LEPm0JbgtPa2JI3Xx3XwkdE1TtDuWCzCJgJIlEVM20Ih0K9R04vpBBvwvbdVO7e0BCMCYKzp23ljJvmXKWc2szygzlha0SeD4MsJ536B06Zt2p1J04dBCHjuLQKoE3KIN1S0Tejg_Cf-nekDXlyoaoXnEuS-ZzzJsaRNRhZc59YVwCu4MEdT8dtPpceRN4sn4dDBnH3NSuWXZtBCbFRAI7ncDXPWEIcRRctQTkhipsdHXzTT09jWDhe8EBDC6cTODFoDXn_fr3WNz__288hqvB-vSHg6PDB3At73Q6qPYubC_Olu5hcNQW9lG0CAJfLtoEfwFrklDn
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modeling+mesenchymal+stromal+cell+support+to+hematopoiesis+within+a+novel+3D+artificial+marrow+organoid+system&rft.jtitle=Scientific+reports&rft.au=Schell%2C+B%C3%A9r%C3%A9nice&rft.au=Zhao%2C+Lin-Pierre&rft.au=M%E2%80%99Sibih%2C+In%C3%A9s&rft.au=Kalogeraki%2C+Maria&rft.date=2025-07-02&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-025-07717-9&rft.externalDocID=10_1038_s41598_025_07717_9
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon